InfraScan lands FDA approval for next-gen non-invasive brain bleed detector
InfraScan lands regulatory approval for its next-generation Infrascanner Model 2000, designed with military specifications for non-invasively detecting bleeding in the brain.
Philadelphia-based medical device maker InfraScan announced FDA approval for its next-generation non-invasive brain bleed detector, the Infrascanner Model 2000.
Developed in partnership with the U.S. Navy and Marine Corps, the Infrascanner 2000 is a more rugged generation of the company's original Infrascanner, which won FDA approval in 2011.
The Infrascanner line uses near-infrared technology to non-invasively detect bleeding in the skull, helping to identify which patients may need a CT scan and quick intervention.